Natural History Study of Nemaline Myopathy in Belgium
Treatments studied
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study follows people with nemaline myopathy over time to understand how the condition progresses naturally. It does not test a treatment, so it helps researchers learn more about the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of nemaline myopathy (a gene-related muscle weakness condition).
- You can be any age, male or female.
- You (and your parent/guardian, if needed) must be willing to sign a consent form to join the study.
- You should not have other serious health issues that could interfere with the study.
- You cannot be currently in another clinical trial that tests an experimental treatment.
- If you are pregnant, some tests may be postponed or skipped.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients with congenital myopathies to understand how their muscles get tired over time. It may help develop better treatments.
This study follows people with nemaline myopathy over time to better understand how the disease progresses. It helps researchers learn more about the condition and plan future treatments.
This study creates a network for children with nemaline myopathy (a muscle weakness condition). It aims to better understand the condition and prepare for future treatments.
This study follows people with LAMA2-related muscular dystrophy or SELENON-related myopathy over 5 years to understand how the condition changes over time. It may help you by tracking your disease progression and contributing to future research.
This study follows people with a rare genetic muscle condition called TNNT1 myopathy over time. Researchers will track how the disease progresses to better understand it and help plan future treatments.
This study follows children with LAMA2-related muscular dystrophy to learn how the condition changes over time. It does not test a new treatment, but helps researchers understand the disease better.
Hear when a new Nemaline Myopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.